Earnings History Data for Cybin Inc. (CYBN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cybin Inc.

Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-02-2024	PM		CYBN	Cybin Inc.	82.69	-0.07	-0.03	-0.04	Cybin reports Q3 results [2/14/2024 7:59 AM]	0.3415	-0.02 (-4.98%)	0.35	0.0 (-1.25%)	0.21 - 0.74	2,183,337	4,020,000	142,307
Cybin reports Q3 results [2/14/2024 7:59 AM]
27-06-2023	AH		CYBN	Cybin Inc.	57.00	-0.05	-0.05	0.00	Cybin reports FY results [6/27/2023 5:09 PM]	0.3180	-0.01 (-3.64%)	0.32	-0.01 (-3.33%)	0.21 - 1.14	1,667,187	2,160,000	55,130
Cybin reports FY results [6/27/2023 5:09 PM]
14-02-2023	PM		CYBN	Cybin Inc.	78.00	-0.04	-0.06	0.00	Cybin Inc reports Q3 results [2/14/2023 7:57 AM]	0.4114	0.0 (0.93%)	0.41	0.0 (0.37%)	0.26 - 1.14	697,571	1,910,000	61,847
Cybin Inc reports Q3 results [2/14/2023 7:57 AM]
14-11-2022	PM	5:05 PM ET (Nov 14)	CYBN	Cybin Inc.	77.00	-0.05	-0.06	0.00	Cybin reports FQ2 results [11/15/2022 4:05 AM]	0.4686	0.01 (2.65%)	0.47	0.01 (2.74%)	0.39 - 2.00	676,636	1,070,000	51,097
Cybin reports FQ2 results [11/15/2022 4:05 AM] Cybin Inc. Reports Second Quarter Financial Results and Recent Business Highlights [Nov-14-22 05:01PM]
08-08-2022	PM		CYBN	Cybin Inc.	103.00	-0.06	-0.08	0.00	Cybin reports FQ1 results [8/9/2022 2:04 AM]	0.7813	0.07 (9.27%)	0.81	0.09 (13.15%)	0.39 - 2.89	875,031	1,110,000	56,510
Cybin stock jumps on announcing at-the-market equity program for up to $35M [8/9/2022 2:13 AM] Cybin reports FQ1 results [8/9/2022 2:04 AM] CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program [Aug-08-22 08:17PM] Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights [Aug-08-22 05:07PM]
22-06-2022	PM		CYBN	Cybin Inc.	95.00	-0.08	-0.07	0.00		0.5569	0.01 (1.31%)	0.57	0.02 (3.69%)	0.39 - 3.38	265,715	670,000	11,665
Cybin reports FY results [6/22/2022 8:28 AM] Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights [Jun-22-22 07:30AM]
10-02-2022	PM	7:30 AM ET (Feb 10)	CYBN	Cybin Inc.	177.24	-0.08	-0.09	-0.07	Cybin Inc reports FQ3 results [2/10/2022 7:33 AM]	1.10	0.04 (3.77%)	1.06	0.0 (0.00%)	0.82 - 3.38	1,286,905	790,000	41,460
Cybin granted U.S. patent for psychedelic-based candidate [2/9/2022 8:38 AM] Cybin Inc reports FQ3 results [2/10/2022 7:33 AM] Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders [Feb-09-22 07:30AM] Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights [Feb-10-22 07:30AM]